Cullen Frost Bankers Inc. reduced its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 6.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 246,031 shares of the company’s stock after selling 16,359 shares during the period. Cullen Frost Bankers Inc.’s holdings in Procter & Gamble were worth $36,053,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Eclectic Associates Inc. ADV grew its position in shares of Procter & Gamble by 22.0% during the third quarter. Eclectic Associates Inc. ADV now owns 2,077 shares of the company’s stock worth $303,000 after acquiring an additional 375 shares during the last quarter. Strategic Investment Advisors MI increased its stake in Procter & Gamble by 2.9% in the third quarter. Strategic Investment Advisors MI now owns 27,371 shares of the company’s stock valued at $3,992,000 after purchasing an additional 770 shares during the period. SevenBridge Financial Group LLC raised its holdings in shares of Procter & Gamble by 2.1% in the third quarter. SevenBridge Financial Group LLC now owns 29,376 shares of the company’s stock valued at $4,285,000 after buying an additional 615 shares during the last quarter. Eukles Asset Management boosted its stake in shares of Procter & Gamble by 77.3% during the third quarter. Eukles Asset Management now owns 9,071 shares of the company’s stock worth $1,323,000 after buying an additional 3,955 shares during the period. Finally, Fortune Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 2.8% during the third quarter. Fortune Financial Advisors LLC now owns 33,489 shares of the company’s stock worth $4,885,000 after buying an additional 927 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Transactions at Procter & Gamble
In related news, COO Shailesh Jejurikar sold 31,859 shares of the stock in a transaction on Monday, May 6th. The stock was sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the sale, the chief operating officer now owns 9,739 shares of the company’s stock, valued at $1,605,961.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, COO Shailesh Jejurikar sold 31,859 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $164.90, for a total value of $5,253,549.10. Following the completion of the transaction, the chief operating officer now owns 9,739 shares of the company’s stock, valued at $1,605,961.10. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now owns 11,507 shares in the company, valued at approximately $1,858,265.43. The disclosure for this sale can be found here. Insiders sold a total of 118,724 shares of company stock valued at $19,312,729 over the last three months. 0.17% of the stock is currently owned by insiders.
Analyst Ratings Changes
Get Our Latest Stock Analysis on PG
Procter & Gamble Price Performance
Shares of PG stock traded up $1.32 during mid-day trading on Tuesday, reaching $165.76. The stock had a trading volume of 6,374,243 shares, compared to its average volume of 6,896,868. The company has a market cap of $391.22 billion, a P/E ratio of 27.09, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $166.04. The business has a 50-day simple moving average of $160.23 and a 200 day simple moving average of $154.49.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm’s revenue for the quarter was up .6% on a year-over-year basis. During the same period last year, the firm posted $1.37 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.85%.
Procter & Gamble Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Garmin Navigates to New Highs Driven By Wearables Trend
- Short Selling: How to Short a Stock
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Most Effectively Use the MarketBeat Earnings Screener
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.